Viewing SEC Facts Units
Company Name:
Aclaris Therapeutics, Inc.
CIK:
1557746
Start Filing Date:
2017-04-01
End Filing Date:
2017-06-30
ACCN:
0001558370-17-006211
Value:
$ 26,594,854
Value Error:
$ None
Created By:
Date Filed:
2017-08-08
FY:
2017
Fiscal Period:
Q2
Frame:
CY2017Q2
Type:
us-gaap
Form:
10-Q
Units:
shares